James R. Kasinger - Net Worth and Insider Trading
James R. Kasinger Net Worth
The estimated net worth of James R. Kasinger is at least $5 Million dollars as of 2025-07-25. James R. Kasinger is the General Counsel and Secretary of CRISPR Therapeutics AG and owns about 81,729 shares of CRISPR Therapeutics AG (CRSP) stock worth over $5 Million. Details can be seen in James R. Kasinger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James R. Kasinger has not made any transactions after 2025-03-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James R. Kasinger
James R. Kasinger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James R. Kasinger owns 1 companies in total, including CRISPR Therapeutics AG (CRSP) .
Click here to see the complete history of James R. Kasinger’s form 4 insider trades.
Insider Ownership Summary of James R. Kasinger
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2025-03-21 | General Counsel and Secretary |
James R. Kasinger Latest Holdings Summary
James R. Kasinger currently owns a total of 1 stock. James R. Kasinger owns 81,729 shares of CRISPR Therapeutics AG (CRSP) as of March 21, 2025, with a value of $5 Million.
Latest Holdings of James R. Kasinger
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2025-03-21 | 81,729 | 66.06 | 5,399,018 |
Holding Weightings of James R. Kasinger
James R. Kasinger Form 4 Trading Tracker
According to the SEC Form 4 filings, James R. Kasinger has made a total of 7 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in CRISPR Therapeutics AG is the sale of 3,185 shares on March 21, 2025, which brought James R. Kasinger around $131,318.
Insider Trading History of James R. Kasinger
- 1
James R. Kasinger Trading Performance
James R. Kasinger Ownership Network
Ownership Network List of James R. Kasinger
Ownership Network Relation of James R. Kasinger
James R. Kasinger Owned Company Details
What does CRISPR Therapeutics AG do?
Who are the key executives at CRISPR Therapeutics AG?
James R. Kasinger is the General Counsel and Secretary of CRISPR Therapeutics AG. Other key executives at CRISPR Therapeutics AG include Chief Financial Officer Raju Prasad , Chief Business Officer Samarth Kulkarni , and Chief Medical Officer Phuong Khanh Morrow .
CRISPR Therapeutics AG (CRSP) Insider Trades Summary
Over the past 18 months, James R. Kasinger made 6 insider transaction in CRISPR Therapeutics AG (CRSP) with a net sale of 25,642. Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 241,024 shares made by Samarth Kulkarni , a net sale of 3,932 shares made by , and a net sale of 9,483 shares made by Raju Prasad .
In summary, during the past 3 months, insiders sold 3,932 shares of CRISPR Therapeutics AG (CRSP) in total and bought 989,812 shares, with a net purchase of 985,880 shares. During the past 18 months, 286,882 shares of CRISPR Therapeutics AG (CRSP) were sold and 996,812 shares were bought by its insiders, resulting in a net purchase of 709,930 shares.
CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.
CRISPR Therapeutics AG Insider Transactions
James R. Kasinger Mailing Address
Above is the net worth, insider trading, and ownership report for James R. Kasinger. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, James R. Kasinger's mailing address is: Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
